Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Video Session 2601

Treatable Hyperkinetic Movement Disorders

Saturday, September 28, 2024
17:30 - 19:00 | Meeting Room 204 AB, 2nd Level

In this session, the faculty will demonstrate phenomenology, etiologies and management of treatable hyperkinetic movement disorders, including metabolic, infectious, and autoimmune disorders.

Margherita Fabbri, France


Soaham Desai, India

Emilia Gatto, Argentina

CSPC Liaisons:
Taku Hatano, Japan

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Describe phenomenology and etiologies of treatable hyperkinetic movement disorders
  2. Explain how to manage treatable hyperkinetic movement disorders

Recommended Audience
Fellow / Resident / Student
Health Professional (non-physician)
Researcher / Basic Science

Education Level
Beginner / Foundational
Experienced / Intermediate

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice